Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 3/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL824215 | 0.96 | MEN1 (0.46) | CYP1A2MEN1KMT2ARXFP1MAPK1 | |
| SCHEMBL29770955 | 0.85 | ESR1 (0.44) | MEN1KMT2ARXFP1MAPK1KDM4E | |
| SCHEMBL23813397 | 0.85 | ESR1 (0.44) | MEN1KMT2ARXFP1MAPK1KDM4E | |
| SCHEMBL21304685 | 0.84 | CYP1A2 (0.52) | CYP1A2MEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL2966882 | 0.83 | GPR84 (0.40) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL29416110 | 0.81 | ESR1 (0.53) | CYP1A2MAPK1SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL574096 | 0.81 | ESR1 (0.53) | CYP1A2MAPK1SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL2293453 | 0.81 | ALDH1A1 (0.43) | CYP1A2MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL7900253 | 0.81 | GPR84 (0.43) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL25410041 | 0.80 | DPP4 (0.48) | CYP1A2MAPK1SMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143781-B2 | Organic electroluminescent compounds with high efficiency and display device using the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-8143781-B2 | Organic electroluminescent compounds with high efficiency and display device using the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-05-12 | — | — | US | disclosed |
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-05-12 | — | — | US | disclosed |
| WO-2009066803-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | EED, EPHA4, NECTIN4 | CYP1A2 2568/4885MEN1 2621/4885KMT2A 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.